Kezar Life Sciences, Inc.

KZR · Nasdaq · SIC 2834: Pharmaceutical Preparations
145
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases. In October 2025, we announced plans to explore strategic alternatives focused on maximizing stockholder value after being unable to align with the U.S. Food and Drug Administration, or FDA, on a potential registrational clinical trial of zetomipzomib, a novel, selective inhibitor of the immunoproteasome in patients with relapsed and refrac...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKZRdiscussed_in_filing Cybersecurity
topic_mentionKZRdiscussed_in_filing Trusted Computing
topic_mentionKZRdiscussed_in_filing Blockchain & Crypto
topic_mentionKZRdiscussed_in_filing Regulation
topic_mentionKZRdiscussed_in_filing Healthcare & Bio
topic_mentionKZRdiscussed_in_filing Sovereign & Government
topic_mentionKZRdiscussed_in_filing Cybersecurity
topic_mentionKZRdiscussed_in_filing Trusted Computing
topic_mentionKZRdiscussed_in_filing Blockchain & Crypto
topic_mentionKZRdiscussed_in_filing Regulation
topic_mentionKZRdiscussed_in_filing Healthcare & Bio
topic_mentionKZRdiscussed_in_filing Sovereign & Government
topic_mentionKZRdiscussed_in_filing Cybersecurity
topic_mentionKZRdiscussed_in_filing Trusted Computing
topic_mentionKZRdiscussed_in_filing Blockchain & Crypto
topic_mentionKZRdiscussed_in_filing Regulation
topic_mentionKZRdiscussed_in_filing Healthcare & Bio
topic_mentionKZRdiscussed_in_filing Sovereign & Government
topic_mentionKZRdiscussed_in_filing Cybersecurity
topic_mentionKZRdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001628280-26-021737EDGAR71K words
2025-03-252024-12-310001645666-25-000010EDGAR—
2024-03-142023-12-310000950170-24-031494EDGAR—
2023-03-142022-12-310000950170-23-007871EDGAR—
2022-03-172021-12-310000950170-22-004085EDGAR—
2021-03-112020-12-310001564590-21-012525EDGAR—
2020-03-122019-12-310001564590-20-010498EDGAR—
2019-03-262018-12-310001564590-19-009369EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001628280-25-051623EDGAR51K words
2025-08-132025-06-300001645666-25-000037EDGAR—
2025-05-132025-03-310001645666-25-000027EDGAR—
2024-11-122024-09-300000950170-24-125457EDGAR—
2024-08-132024-06-300000950170-24-096213EDGAR—
2024-05-092024-03-310000950170-24-056918EDGAR—
2023-11-132023-09-300000950170-23-062950EDGAR—
2023-08-102023-06-300000950170-23-041332EDGAR—
2023-05-112023-03-310000950170-23-021257EDGAR—
2022-11-102022-09-300000950170-22-024486EDGAR—
2022-08-112022-06-300000950170-22-016897EDGAR—
2022-05-122022-03-310000950170-22-009686EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001628280-26-023703EDGAR3K words
2026-03-300001193125-26-130486EDGAR—
2026-03-120001628280-26-017046EDGAR—
2025-11-120001628280-25-051592EDGAR—
2025-11-070001628280-25-050671EDGAR—
2025-10-220001628280-25-045871EDGAR—
2025-10-160001628280-25-045215EDGAR—
2025-08-130001645666-25-000036EDGAR—
2025-06-230001645666-25-000029EDGAR—
2025-05-130001645666-25-000026EDGAR—

145 total filings indexed. 115 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001645666
TickerKZR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7813ca383c7a7dec52452ba7c0b013dcb211666d68059a8c8876ddb871004d4f
parent: 4b17ff6807e9a98790b5a93ff3f213b4a99861dc36c4600219b5283158105c1b
content hash: 926eedb1202f43f5ffc861eefe3a5ac2aa817fa8fb15cb8495b31711047b9503
signed: 2026-04-13T04:45:57.725Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf